Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 12;326(14):1436-1438.
doi: 10.1001/jama.2021.15265.

Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021

Sophie Uyoga  1 , Ifedayo M O Adetifa  1 , Mark Otiende  1 , Christine Yegon  2 , Ambrose Agweyu  1 , George M Warimwe  1 , J Anthony G Scott  1
Affiliations

Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021

Sophie Uyoga et al. JAMA. .

Erratum in

  • Error in Additional Contributions.
    [No authors listed] [No authors listed] JAMA. 2021 Oct 26;326(16):1637. doi: 10.1001/jama.2021.16158. JAMA. 2021. PMID: 34559186 Free PMC article. No abstract available.
  • Unclear Diagnostic Testing Standard.
    [No authors listed] [No authors listed] JAMA. 2021 Oct 26;326(16):1637. doi: 10.1001/jama.2021.17311. JAMA. 2021. PMID: 34698803 Free PMC article. No abstract available.

Abstract

This study examines the prevalence of SARS-CoV-2 antibodies among blood donors aged 16 to 64 years in Kenya from January to March 2021.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Warimwe reported receiving grants from Wellcome Trust during the conduct of the study. Dr Scott reported receiving grants from the Bill and Melinda Gates Foundation, the UK Foreign Commonwealth and Development Office, and Wellcome Trust during the conduct of the study and grants from Gavi, the Vaccine Alliance, the National Institute for Health Research, and the Medical Reserve Corps outside the submitted work. No other disclosures were reported.

References

    1. Weekly national influenza and COVID-19 surveillance report: week 24 report (up to week 23 data). Public Health England . Accessed June 17, 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploa...
    1. Uyoga S, Adetifa IMO, Karanja HK, et al. . Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors. Science. 2021;371(6524):79-82. - PMC - PubMed
    1. Adetifa IMO, Uyoga S, Gitonga JN, et al. . Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya. Nat Commun. 2021;12(1):3966. doi:10.1038/s41467-021-24062-3 - DOI - PMC - PubMed
    1. Etyang AO, Lucinde R, Karanja K, et al. . Seroprevalence of antibodies to severe acute respiratory syndrome coronavirus 2 among healthcare workers in Kenya. Clin Infect Dis. Published online April 23, 2021. doi:10.1093/cid/ciab346 - DOI - PMC - PubMed
    1. Mattiuzzo G, Bentley EM, Hassall M, et al. . Establishment of the WHO International Standard and Reference Panel for Anti-SARS-CoV-2 Antibody. World Health Organization; 2020.

Publication types

Substances